An extended-acting IGF-1 analog studied for anabolic signaling and cell survival.
TR8CE uses one simple standard: 0.1 mL of bacteriostatic water per mg. A 1 mg vial takes 0.25 mL of water for a clean 4 mg/mL solution. Larger vials scale the water up to fit the glass.
| Vial size | BAC water | Concentration | 50 mcg draws to |
|---|---|---|---|
| 1 mg | 0.25 mL | 4 mg/mL | 1.25 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 50 mcg. At 4 mg/mL, that draws to 1.25 units on a U-100 insulin syringe.
Binds IGF-1 receptors in muscle and other tissues to activate anabolic signaling. It also inhibits programmed cell death.
IGF-1 LR3 is commonly taken in the morning.
Add 0.25 mL of bacteriostatic water to a 1 mg IGF-1 LR3 vial for a 4 mg/mL solution.
A common IGF-1 LR3 starting dose is 50 mcg, which at 4 mg/mL draws to 1.25 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the IGF-1 LR3 vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.